Gohibic
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gohibic, covering 2026-03-17 to 2026-03-17. Get the full timeline:
Most recent: EMA Authorised: Gohibic (vilobelimab) — InflaRx GmbH
1 regulatory and trial event tracked for Gohibic, covering 2026-03-17 to 2026-03-17. Get the full timeline:
Most recent: EMA Authorised: Gohibic (vilobelimab) — InflaRx GmbH